| 1 |
Serum testosterone and prostate specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients |
|
|
| Gede Wirya Kusuma Duarsa,Yudit Anastasia Sari,Anak Agung Gde Oka,Kadek Budi Santosa,I Wayan Yudiana,Pande Made Wisnu Tirtayasa,Ida Bagus Putra Pramana,Yudhistira Pradnyan Kloping |
|
| Asian Journal of Urology. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer |
|
|
| Teng-Kai Yang,Chia-Chang Wu,Chao-Hsiang Chang,Chih-Hsin Muo,Chao-Yuan Huang,Chi-Jung Chung |
|
| Medicine. 2020; 99(7): e18842 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer |
|
|
| Monyse de Nóbrega,Heloisa Lizotti Cilião,Marilesia Ferreira de Souza,Milene Roldão de Souza,Juliana Mara Serpeloni,Paulo Emilio Fuganti,Ilce Mara de Syllos Cólus |
|
| Genetics and Molecular Biology. 2020; 43(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Obesity’s role in secondary male hypogonadism: a review of pathophysiology and management issues |
|
|
| Omar Seyam,Jason Gandhi,Gunjan Joshi,Noel L. Smith,Sardar Ali Khan |
|
| SN Comprehensive Clinical Medicine. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Prostate volume index and prostatic chronic inflammation predicted low tumor load in 945 patients at baseline prostate biopsy |
|
|
| Antonio B. Porcaro,Alessandro Tafuri,Marco Sebben,Giovanni Novella,Tania Processali,Marco Pirozzi,Nelia Amigoni,Riccardo Rizzetto,Aliasger Shakir,Arianna Mariotto,Matteo Brunelli,Maria Angela Cerruto,Giovanni Enrico Cacciamani,Filippo Migliorini,Salvatore Siracusano,Walter Artibani |
|
| World Journal of Urology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Sex hormones and oxidative stress mediated phthalate-induced effects in prostatic enlargement |
|
|
| Wei-Hsiang Chang,Yuh-Shyan Tsai,Jia-Yu Wang,Hsiu-Ling Chen,Wen-Horng Yang,Ching-Chang Lee |
|
| Environment International. 2019; 126: 184 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
“Prostate telocytes change their phenotype in response to castration or testosterone replacement” |
|
|
| Sérgio Luis Felisbino,Bruno Domingos Azevedo Sanches,Flávia Karina Delella,Wellerson Rodrigo Scarano,Fernanda Cristina Alcântara Dos Santos,Patrícia Simone Leite Vilamaior,Sebastião Roberto Taboga,Luis Antônio Justulin |
|
| Scientific Reports. 2019; 9(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
The association between body mass index and testosterone deficiency in aging Chinese men with benign prostatic hyperplasia: results from a cross-sectional study |
|
|
| Yu Wu,Ding Xu,Hai-Bo Shen,Su-Bo Qian,Jun Qi,Xu-Jun Sheng |
|
| The Aging Male. 2019; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Association between the symptoms of benign prostatic hyperplasia and social disparities: Does social capital promote prostate health? |
|
|
| Myung-Bae Park,Dae Sung Hyun,Jae Mann Song,Hyun Chul Chung,Sung Won Kwon,Sae Chul Kim,Chhabi Lal Ranabhat,Tae Sic Lee,Sang-Baek Koh |
|
| Andrologia. 2018; : e13125 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach |
|
|
| Adriana Albini,Antonino Bruno,Barbara Bassani,Gioacchino D’Ambrosio,Giuseppe Pelosi,Paolo Consonni,Laura Castellani,Matteo Conti,Simone Cristoni,Douglas M. Noonan |
|
| Frontiers in Endocrinology. 2018; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Methyl jasmonate reduces testosterone-induced benign prostatic hyperplasia through regulation of inflammatory and apoptotic processes in rats |
|
|
| Oluwatosin Adekunle Adaramoye,Olubukola Oyebimpe Akanni,Olusoji John Abiola,Solomon Eduviere Owumi,Oluyemi Akinloye,Emiola Olubunmi Olapade-olaopa |
|
| Biomedicine & Pharmacotherapy. 2017; 95: 1493 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
Withania coagulans Extract Induces Cell Apoptosis and Inhibits COX-2 Expression in a Rat Model of Benign Prostatic Hyperplasia |
|
|
| Maryam Sarbishegi,Ozra Khajavi,Mohammad Reza Arab |
|
| Nephro-Urology Monthly. 2016; Inpress(Inpress) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Testosterone Replacement Therapy on the Natural History of Prostate Disease |
|
|
| Aaron Moore,Michael J. Butcher,Tobias S. Köhler |
|
| Current Urology Reports. 2015; 16(8) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Controversies in testosterone supplementation therapy |
|
|
| Mohit Khera |
|
| Asian Journal of Andrology. 2015; 17(2): 175 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
